The Overview: December 2021
This time of year always has us reflecting on what we’ve accomplished, what we hope to achieve in the future, and how we — with the support of the entire ovarian cancer … Continued
News
Announcing The Edmée Firth Fund for Research in Ovarian Cancer
Ovarian Cancer Research Alliance (OCRA) is proud to announce the establishment of a major new research partnership with Nicholas Firth and the Jean & Louis Dreyfus Foundation to be known as The … Continued
OCRA-Funded Research Identifies New “Master” Drug Targets for Ovarian Cancer
An interdisciplinary group of researchers from around the country analyzed tumor samples from nearly 10,000 patients with 34 types of cancer to reveal unique genetic switches associated with each tumor … Continued
Apply Today for OCRA’s 2022 Advocate Leader Program
The application period has now closed. Apply today to join survivors, caregivers and activists across the country to affect change for those impacted by ovarian cancer. Advocate Leaders will learn how to … Continued
Liya Ding, PhD | Meet a Scientist
Dr. Liya Ding, of Dana-Farber Cancer Institute, is a 2021 recipient of OCRA’s Liz Tilberis Early Career Award. With her project, “Targeting Therapeutic Resistance to PARP Inhibition in Ovarian Cancer,” … Continued
Bojana Stefanovska, PhD | Meet a Scientist
Dr. Bojana Stefanovska, at University of Minnesota Twin Cities, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award. Her project, “APOBEC3B and DNA Repair as Synthetic … Continued
A Thanksgiving Message from Audra Moran, President & CEO
Dear Friends, I hope this finds you all well, staying safe, and enjoying preparations for a lovely holiday. Whether you’re gathering with loved ones or holding them in your heart as … Continued
The Overview: November 2021
As we head into the Thanksgiving holiday, we have much to be thankful for … an embracing and strong survivor community, supporters who remain ever committed to the cause, and … Continued
Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act
Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge. To address both financial … Continued
OCRA-Funded Study Points to New Approach to Improve Ovarian Cancer Treatment
The following is a press release from University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, and Magee-Womens Research Institute PITTSBURGH, Nov. 12, 2021 – Immune checkpoint inhibitors are a … Continued
The Overview: October 2021
Have we got a roundup in store! You heard from us a lot in September (thanks to you, we surpassed our Ovarian Cancer Awareness Month fundraising goal!) and there’s still … Continued
Join Us: OCRA’s Virtual Fall Advocacy Day
November 15-16, 2021 | Register Today! Are you passionate about issues affecting the ovarian cancer community? Now is your chance to have your voice heard at the highest levels — … Continued